The new Share Repurchase Program authorizes ... Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon are trademarks owned by the Ascendis Pharma Group.
Presented new data demonstrating additional benefits ... Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA®, and YORVIPATH® are trademarks owned by ...
Guided by its core values of Patients, Science, and Passion, Ascendis uses its TransCon technologies to create new and potentially ... the Ascendis Pharma logo, the company logo and TransCon ...
Explore Ascendis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ASND. Why Is BioMarin Stock Trading Higher On Thursday? BioMarin exceeded Q4 ...
Shares of ASND opened at $152.61 on Tuesday. Ascendis Pharma A/S has a 52 week low of $111.09 and a 52 week high of $158.06. The stock has a market capitalization of $9.26 billion, a price-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback